Ncardia, a global leader in human induced pluripotent stem cell (hiPSC) technology, today announced the launch of Ncyte® ...

“The problem with the Alzheimer’s group is they were very co-opted,” said Peter J. Whitehouse, MD, PhD, a professor of ...

India's first Guillain-Barre Syndrome death reported in Maharashtra—what’s causing the outbreak, who’s at risk. Read on to ...

Guillain Barre Syndrome (GBS), a post-infectious neurological disease, is spreading in Pune with over 100 cases reported. A ...

As Maharashtra reports first death from the neurological condition, doctors explain the rise in cases, symptoms to watch for, ...

One person is believed to have died in India's Maharashtra state in an outbreak of Guillain-Barre syndrome (GBS) - a neurological disease that causes numbness, weakness and pain - and the number of ...

Guillain-Barré Syndrome is a rare but potentially life-threatening disorder. The early signs include tingling, muscle ...

LEQEMBI ® [ (lecanemab-irmb) 100 mg/mL injection for intravenous use] is indicated for the treatment of Alzheimer's disease (AD). Treatment with LEQEMBI should be initiated in patients with mild ...

MNDs are neurological disorders that destroy motor neurons, the cells that control skeletal muscle activity such as walking, breathing, speaking, and swallowing.

Revolutionary nasal spray offers hope by potentially delaying Alzheimer's progression through cutting-edge neurological ...

Ibadan, Dr. Temitope Farombi, has warned that by 2030, Nigerians are projected to experience three times the current burden of brain disorders.